Clinical trial
Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a…
NCT00436527 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00436527 |
|---|---|
| Title | Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application |
| Official title | MetroGel 1% Hydration Study: A Kinetic Regression Study |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Rosacea |
| Intervention type | Drug |
| Interventions | Metronidazole gel 1% |
| Enrollment | 26 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Feb 19, 2007 |
| Last update posted | Jul 29, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: